None listed
Conditions
Interventions
"Intensive treatment" (intravenous insulin infusion for 24 hours followed by tight glycaemic control aiming BGL 4.5 - 7mmol/L throughout admission).
Sponsors
Melbourne Health
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Non ST Non ST elevation myocardial infarct within 24 hoursBGL >=10mmol/Lelevation myocardial infarct within 24 hoursBGL >=10mmol/L
Exclusion criteria
Current infection; Active inflammatory conditions; Women of child bearing potential; Known cardiac shuntInsulin allergy.
Outcome results
None listed